Combination treatment with metronomic temozolomide, bevacizumab and long-acting octreotide for malignant neuroendocrine tumours (Q35665113)
Jump to navigation
Jump to search
scientific article published on 9 January 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Combination treatment with metronomic temozolomide, bevacizumab and long-acting octreotide for malignant neuroendocrine tumours |
scientific article published on 9 January 2012 |
Statements
1 reference
Combination treatment with metronomic temozolomide, bevacizumab and long-acting octreotide for malignant neuroendocrine tumours (English)
1 reference
Anna Koumarianou
1 reference
Stavroula Antoniou
1 reference
George Kanakis
1 reference
Nikolaos Economopoulos
1 reference
Dimitra Rontogianni
1 reference
Anastasios Ntavatzikos
1 reference
Nikolaos Tsavaris
1 reference
Dimitrios Pectasides
1 reference
George Dimitriadis
1 reference
Gregory Kaltsas
1 reference
9 January 2012
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference